A detailed history of C M Bidwell & Associates LTD transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 5 shares of DNA stock, worth $46. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 234 97.86%
Holding current value
$46
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.22 - $9.31 $50 - $2,131
-229 Reduced 97.86%
5 $0
Q1 2024

May 13, 2024

SELL
$1.06 - $1.67 $815 - $1,284
-769 Reduced 76.67%
234 $0
Q4 2022

Feb 10, 2023

BUY
$1.63 - $3.52 $1,253 - $2,706
769 Added 328.63%
1,003 $1,000
Q1 2022

Apr 29, 2022

BUY
$2.83 - $8.69 $662 - $2,033
234 New
234 $1,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.